Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-02-20 Sale |
2025-02-24 4:21 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
3,305 | $4.26 | $14,079 | 215,718 (Direct) |
View |
2025-02-11 Sale |
2025-02-12 4:22 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,413 | $4.45 | $24,088 | 81,023 (Direct) |
View |
2025-01-14 Sale |
2025-01-15 4:17 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
1,191 | $5.13 | $6,110 | 86,436 (Direct) |
View |
2024-02-20 Sale |
2024-02-22 4:30 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
3,967 | $7.5019 | $29,760 | 87,627 (Direct) |
View |
2024-01-17 Sale |
2024-01-19 4:32 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
1,266 | $7.18 | $9,090 | 53,094 (Direct) |
View |
2023-09-15 Sale |
2023-09-18 4:44 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
10,500 | $8.16 | $85,680 | 94,360 (Direct) |
View |
2023-07-06 Sale |
2023-07-10 4:42 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,500 | $10.8 | $59,400 | 59,860 (Direct) |
View |
2023-06-30 Sale |
2023-07-05 4:32 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,000 | $11.41 | $57,050 | 110,360 (Direct) |
View |
2023-03-20 Sale |
2023-03-22 4:49 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
2,193 | $7.76 | $17,018 | 65,360 (Direct) |
View |
2023-02-17 Sale |
2023-02-22 8:57 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
738 | $7.45 | $5,498 | 135,553 (Direct) |
View |
2023-02-13 Sale |
2023-02-15 4:53 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
797 | $7.67 | $6,113 | 34,291 (Direct) |
View |
2023-01-17 Sale |
2023-01-19 4:55 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
1,106 | $9.8485 | $10,892 | 35,088 (Direct) |
View |
2023-01-06 Sale |
2023-01-10 4:07 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
388 | $6.41 | $2,487 | 36,194 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-21 Option Award |
2025-02-24 4:21 pm |
N/A 2035-02-21 |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
138,000 | $0 | 215,718 (Direct) |
View |
2024-02-09 Option Award |
2024-02-16 5:04 pm |
N/A 2034-02-09 |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
115,500 | $0 | 168,594 (Direct) |
View |
2023-09-15 Exercise |
2023-09-18 4:44 pm |
N/A 2032-01-13 |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,000 | $0 | 94,360 (Direct) |
View |
2023-09-15 Exercise |
2023-09-18 4:44 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,000 | $2.85 | 94,360 (Direct) |
View |
2023-06-30 Exercise |
2023-07-05 4:32 pm |
N/A 2032-01-13 |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,000 | $0 | 110,360 (Direct) |
View |
2023-06-30 Exercise |
2023-07-05 4:32 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,000 | $2.85 | 110,360 (Direct) |
View |
2023-02-17 Option Award |
2023-02-22 8:57 pm |
N/A 2033-02-17 |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
102,000 | $0 | 135,553 (Direct) |
View |
2022-12-31 Option Award |
2023-01-10 4:07 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
388 | $5.17 | 36,194 (Direct) |
View |
2022-09-19 Option Award |
2022-09-21 4:42 pm |
N/A 2032-09-19 |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
165,000 | $0 | 165,000 (Direct) |
View |
Ownership |
2022-09-21 4:39 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
0 | $0 | 210,120 (Direct) |
View |